A multicenter case-control study in Iran reported that self-reported prolonged mobile phone use was associated with higher odds of confirmed and suspected breast cancer status. The authors emphasize that the findings do not imply causation and note limitations including self-reported exposure and potential residual confounding. They call for larger prospective studies with objective exposure assessment.

RF Safe argues that marketing claims such as “blocks 99% of EMF” for anti-radiation phone cases are misleading because many “lab tests” are reportedly performed on shielding fabric alone rather than on a working phone. The piece frames a phone as a “dynamic radio” and suggests real-world performance may differ from simplified test setups. The extracted text also promotes RF Safe’s products and warranty, indicating a commercial/advocacy context.

This PubMed-listed in vitro study tested whether 1800 MHz RF-EMF exposure can modify chemically induced DNA damage in mouse embryonic fibroblasts under standardized, non-thermal conditions. The authors report RF-EMF alone did not produce detectable DNA damage and did not significantly increase damage from hydrogen peroxide, 4-nitroquinoline-1-oxide, or cadmium. However, co-exposure with hexavalent chromium (Cr(VI)) was reported to synergistically increase DNA damage in the comet assay, which the authors interpret as possible selective exacerbation of Cr(VI)-induced genotoxicity requiring further investigation.

A rat study in Bioelectromagnetics examined GSM-modulated 3.5 GHz RF-EMF exposure (2 h/day for 30 days) and reported adverse changes in male reproductive hormones, oxidative stress markers, and testicular histology. The authors also tested Coenzyme Q10 (CoQ10) and found it partially ameliorated some RF-associated alterations. The paper notes that because the exposure used a GSM-modulated waveform, findings cannot be extrapolated to FR1 5G NR signals, and calls for further research under real-world conditions.

This RF Safe commentary argues that HHS, under Secretary Robert F. Kennedy Jr., was correct to remove FDA webpages that gave broad assurances that cell phone radiation is “not dangerous.” It claims blanket safety messaging is scientifically indefensible given animal toxicology findings (notably the U.S. National Toxicology Program studies), a WHO-commissioned systematic review of animal cancer studies (Mevissen et al., 2025), and references to federal court findings. The piece frames the change as a precautionary, science-based correction rather than an anti-science move.

This RF Safe commentary argues that Reuters-reported actions by HHS and FDA—launching an HHS study and removing older FDA webpages stating cellphones are “not dangerous”—should be understood as a risk-communication/scientific-integrity adjustment rather than a declaration of confirmed harm. It contends that categorical safety messaging is not justified given mixed evidence, citing the D.C. Circuit’s 2021 decision criticizing FCC reliance on conclusory FDA statements, along with selected human, animal, and mechanistic literature. The post calls for more uncertainty-aware, evidence-graded public messaging about RF exposure from phones.

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

RF Safe reports that HHS confirmed plans to launch a new study on cellphone radiation and that an HHS spokesperson said the FDA removed webpages with “old conclusions” while new research is undertaken to identify knowledge gaps, including for emerging technologies. The article frames the FDA webpage changes as a meaningful shift away from categorical reassurance, while noting Reuters’ reporting that some FDA and CDC pages still state there is no credible evidence of health problems from cellphone radiation. It also links the development to the 2021 D.C. Circuit decision in Environmental Health Trust v. FCC, arguing the ruling exposed weaknesses in the FCC’s reliance on other agencies’ statements.

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

RF Safe recounts a timeline of FTC actions and consumer guidance targeting phone “radiation shield” stickers/patches that claimed large reductions in exposure, arguing these products can create a false sense of security. The post cites the FTC’s February 2002 enforcement actions and consumer alert, including references to Good Housekeeping Institute testing that reportedly found the products did not reduce exposure. RF Safe also claims it warned about such scams earlier (late 1990s), framing this as its own account rather than an FTC-attributed origin story.

RF Safe promotes its QuantaCase (also called TruthCase) as a leading “anti-radiation” phone case for 2026, emphasizing a directional shielding design intended to deflect RF energy away from the body. The article argues the product aligns with consumer-safety guidance such as keeping phones away from the body and using hands-free modes, and it claims RF Safe’s earlier advocacy influenced FTC/FCC warnings about ineffective or counterproductive shielding products. It cites comparisons, user reviews, and an “independent” 2017 TV review as support, but presents limited verifiable technical detail in the excerpt.

RF Safe critiques the anti-radiation phone case market for relying on headline percentage-blocking claims that may reflect tests of shielding material rather than real-world phone behavior in a case on a live network. The article argues that poorly designed or misused shielding cases can interfere with a phone’s signal and prompt higher transmit power, potentially increasing exposure in some scenarios. It positions RF Safe’s QuantaCase/TruthCase as avoiding percentage marketing claims and emphasizes a systems-engineering approach to testing and use, while noting that health causation from typical consumer RF exposure remains debated by authorities.

RF Safe argues that “anti-radiation” phone case marketing based on universal “99% blocking” claims is misleading because real-world phone emissions vary with signal conditions, orientation, and how a case affects the antenna. The post positions RF Safe’s TruthCase/QuantaCase as more credible specifically because it refuses to advertise a single percentage reduction and instead emphasizes design constraints intended to avoid prompting a phone to increase transmit power. It cites a KPIX 5 (CBS San Francisco) test as an example of how flip cases can reduce exposure in some configurations but potentially increase it in others when used differently than intended.

RF Safe argues that many “anti-radiation” phone cases market misleading “% blocked” claims based on lab material tests rather than whole-device, real-world performance. The article promotes RF Safe’s TruthCase/QuantaCase as a “physics-first” design that avoids advertising a single blocking percentage and emphasizes directional shielding and user education. It cites a 2017 CBS San Francisco/KPIX test as an example of how some flip-style shielding cases can reduce measured RF in certain orientations but may increase readings in other common-use configurations.

This PubMed-listed paper argues that the U.S. regulatory framework for radiofrequency radiation (RFR) from wireless technologies is outdated, lacks adequate oversight and enforcement, and has not been meaningfully updated since 1996. It contends that FCC exposure limits focus on short-term, high-intensity effects and do not address long-term, low-intensity exposures, with insufficient safeguards for children, pregnancy, and other vulnerable groups. The authors also discuss alleged regulatory capture, gaps in monitoring and compliance, and propose reforms including independent research, updated safety limits, and stronger pre- and post-market surveillance.

RF Safe criticizes Media Bias Fact Check (MBFC) for labeling RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility,” arguing MBFC’s entry contains factual errors and misrepresentations. The post says RF Safe does not claim RF radiation definitively causes human disease, but instead presents precautionary interpretations of peer-reviewed studies and proposed non-thermal mechanisms. It also alleges MBFC made specific, checkable mistakes about study-linking practices and site ownership/funding, and failed to correct them after rebuttals.

RF Safe argues that many “anti-radiation” phone cases use misleading marketing (e.g., fabric-swatch tests, vague “FCC tested” claims) and that some designs may cause phones to increase transmit power if they interfere with antennas. The article provides a checklist of red flags (magnets/metal plates, detachable shields, unclear orientation instructions) and emphasizes behavioral steps to reduce RF exposure. It promotes RF Safe’s QuantaCase as a “directional shielding” design intended to reduce exposure on the body-facing side while avoiding signal blockage that could prompt higher power output.

RF Safe promotes an “Act Now” hub intended to convert EMF safety concerns into policy and regulatory actions, emphasizing accountability and exposure reduction, especially for children. The page outlines five advocacy “levers,” including changing Section 704 of the Telecommunications Act, pressing the FCC to complete actions following a court remand, and restarting a federal electronic-product radiation program. It frames current RF oversight as outdated and insufficient for modern exposure patterns, and provides scripts to help supporters submit comments and demands into official records.

This article summarizes expert presentations and a panel discussion on radiological protection systems for ionizing and non-ionizing radiation at an international congress. It highlights that ionizing radiation protection is mature and continually revised, while non-ionizing radiation protection lacks a comparable international framework. The authors emphasize that emerging non-ionizing technologies create complex exposure scenarios and unresolved concerns about chronic and acute exposures, calling for a more cohesive and protective framework.

This animal study tested whether short-term 28 GHz (5G-band) millimeter-wave exposure modifies doxorubicin-induced cardiotoxicity in male rats and whether vitamin C mitigates effects. Co-exposure to 28 GHz EMR was reported to worsen several indices of DOX-related cardiac injury (including CAT reduction, increased BAX expression, and QT prolongation), while vitamin C provided partial attenuation. The authors emphasize that results are limited to a short-duration preclinical model and that human relevance remains preliminary.